ENDOSTARSIL HEMOSTAT
LIVE

Serial Number

79399821

Owner

Hemostat Manufacturing GmbH

Attorney

Bryan W. Bockhop

Filing Date

Apr 16, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ENDOSTARSIL HEMOSTAT Trademark

Serial Number: 79399821 • Registration: 7895220

ENDOSTARSIL HEMOSTAT is a trademark filed by Hemostat Manufacturing GmbH on April 16, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Hemostat Manufacturing GmbH (3 trademarks)

Beckelmannsweg 10

Entity Type: 99

Trademark Details

Filing Date

April 16, 2024

Registration Date

August 19, 2025

Published for Opposition

July 1, 2025

Goods & Services

Medical and veterinary endoscopes for introducing blood clotting agents and blood clotting powder into the human or animal body; orally inserted medical and veterinary endoscopes for introducing blood clotting agents and blood clotting powder into the human or animal body; medical and veterinary endoscopes for colonoscopy for introducing blood clotting agents and blood clotting powder into the human or animal body

Chemical preparations for medical purposes, namely, for improving blood coagulation and supporting natural blood cascade, and for improving blood coagulation and supporting natural blood cascade during and after surgical procedure and emergency treatments; chemical preparations for pharmaceutical purposes, namely, for improving blood coagulation and supporting natural blood cascade, and for improving blood coagulation and supporting natural blood cascade during and after surgical procedure and emergency treatments; chemical preparations for veterinary purposes, namely, for improving blood coagulation and supporting natural blood cascade, and for improving blood coagulation and supporting natural blood cascade during and after surgical procedure and emergency treatments; chemico-pharmaceutical preparations for improving blood coagulation and supporting natural blood cascade; surgical tissues, namely, surgical implants comprising living tissues; haemostatic preparations, namely, pharmaceutical preparations being hemostatic agents for blood clotting; antihaemophilic factor, namely, pharmaceutical preparations for treating hemophilia; pharmaceutical preparations, namely, blood clotting powder; medical dressing with blood clotting properties; pharmaceutical preparations for improving blood coagulation and supporting natural blood cascade, and for improving blood coagulation and supporting natural blood cascade during and after surgical procedure and emergency treatments; medical plasters, medical dressings, namely, materials for medical dressings; medical dressings; surgical dressings; absorbable surgical dressings; blood clotting, absorbable surgical dressings

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 19, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 2, 2026 FICS
FINAL DISPOSITION PROCESSED
Mar 2, 2026 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 25, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 10, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 10, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 19, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 19, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 19, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 1, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 1, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 25, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 30, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
May 30, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 30, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
May 30, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 30, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 29, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 29, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 29, 2025 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 24, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 24, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 24, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 24, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 24, 2025 COAR
REFUSAL PROCESSED BY IB
Nov 23, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 7, 2024 RFCS
REFUSAL PROCESSED BY MPU
Nov 7, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 31, 2024 RFCR
NON-FINAL ACTION WRITTEN
Oct 30, 2024 CNRT
ASSIGNED TO EXAMINER
Oct 29, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 15, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 15, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 11, 2024 REPR